Fifth Third Bancorp’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-357
| Closed | -$35.1K | – | 2668 |
|
|
2025
Q2 | $35.1K | Buy |
357
+9
| +3% | +$852 | ﹤0.01% | 1558 |
|
|
2025
Q1 | $32.2K | Buy |
348
+141
| +68% | +$13K | ﹤0.01% | 1587 |
|
|
2024
Q4 | $18.8K | Sell |
207
-112
| -35% | -$10.3K | ﹤0.01% | 1767 |
|
|
2024
Q3 | $30.8K | Buy |
319
+2
| +0.6% | +$195 | ﹤0.01% | 1621 |
|
|
2024
Q2 | $29.1K | Buy |
317
+29
| +10% | +$2.69K | ﹤0.01% | 1592 |
|
|
2024
Q1 | $26.5K | Buy |
288
+18
| +7% | +$1.69K | ﹤0.01% | 1583 |
|
|
2023
Q4 | $25.7K | Sell |
270
-7
| -3% | -$654 | ﹤0.01% | 1677 |
|
|
2023
Q3 | $25.9K | Sell |
277
-800
| -74% | -$73.9K | ﹤0.01% | 1637 |
|
|
2023
Q2 | $98.5K | Sell |
1,077
-200
| -16% | -$16.4K | ﹤0.01% | 1153 |
|
|
2023
Q1 | $93.9K | Sell |
1,277
-183
| -13% | -$15.8K | ﹤0.01% | 1221 |
|
|
2022
Q4 | $122K | Sell |
1,460
-191
| -12% | -$17.2K | ﹤0.01% | 1076 |
|
|
2022
Q3 | $160K | Buy |
1,651
+47
| +3% | +$5.61K | ﹤0.01% | 989 |
|
|
2022
Q2 | $169K | Sell |
1,604
-102
| -6% | -$13K | ﹤0.01% | 998 |
|
|
2022
Q1 | $294K | Buy |
1,706
+799
| +88% | +$119K | ﹤0.01% | 876 |
|
|
2021
Q4 | $147K | Buy |
907
+317
| +54% | +$50.9K | ﹤0.01% | 1113 |
|
|
2021
Q3 | $88K | Buy |
590
+3
| +0.5% | +$624 | ﹤0.01% | 1217 |
|
|
2021
Q2 | $144K | Sell |
587
-12
| -2% | -$3.15K | ﹤0.01% | 1070 |
|
|
2021
Q1 | $159K | Buy |
599
+196
| +49% | +$55.3K | ﹤0.01% | 1015 |
|
|
2020
Q4 | $118K | Sell |
403
-44
| -10% | -$11.3K | ﹤0.01% | 1099 |
|
|
2020
Q3 | $106K | Sell |
447
-34
| -7% | -$7.73K | ﹤0.01% | 1099 |
|
|
2020
Q2 | $95K | Sell |
481
-95
| -16% | -$17.7K | ﹤0.01% | 1110 |
|
|
2020
Q1 | $106K | Sell |
576
-25
| -4% | -$4.45K | ﹤0.01% | 1029 |
|
|
2019
Q4 | $100K | Buy |
601
+179
| +42% | +$26.6K | ﹤0.01% | 1160 |
|
|
2019
Q3 | $55K | Buy |
422
+21
| +5% | +$2.73K | ﹤0.01% | 1317 |
|
|
2019
Q2 | $49K | Buy |
+401
| New | +$47.6K | ﹤0.01% | 1348 |
|
|
2016
Q1 | – | Sell |
-79
| Closed | -$3K | – | 2314 |
|
|
2015
Q4 | $3K | Buy |
79
+1
| +1% | +$40 | ﹤0.01% | 2319 |
|
|
2015
Q3 | $3K | Buy |
78
+17
| +28% | +$717 | ﹤0.01% | 2449 |
|
|
2015
Q2 | $2K | Buy |
61
+1
| +2% | +$31 | ﹤0.01% | 2534 |
|
|
2015
Q1 | $2K | Buy |
+60
| New | +$1.69K | ﹤0.01% | 2437 |
|
Other funds holding AMED
IA
MCI
HNB
Fifth Third Bancorp's AMED Position: Q3 2025 in Review
Fifth Third Bancorp sold out of Amedisys (AMED) in Q3 2025, closing a stake of 357 shares — an estimated $35.1K sold.
Fifth Third Bancorp first reported a position in AMED in Q1 2015 and held it in 29 quarters. The position peaked at $294K in Q1 2022. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Fifth Third Bancorp reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Fifth Third Bancorp sold 357 Amedisys shares in Q3 2025, an estimated $35.1K.
- Fifth Third Bancorp first reported a position in Amedisys in Q1 2015 and held it in 29 quarters.
- Fifth Third Bancorp's Amedisys position peaked at $294K in Q1 2022.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Fifth Third Bancorp's 13F filing for Q3 2025, filed 7 Nov 2025.